Margin Breakdown
| Pretax Profit Margin | (3.49) | |
| Operating Profit Margin | (2.82) | |
| Net Profit Margin | (3.5) | |
| Gross Profit Margin | (0.73) |
Danimer Scientific (USA Stocks:DNMR) is to drop even more in August
 | By Rifka Kats | Macroaxis Story |
Approximately 38.0% of Danimer Scientific's shares are owned by institutional investors, such as insurance companies. Insider ownership in Danimer Scientific pertains to the equity held by the company's officers, directors, leadership team relatives, or anyone with access to non-public information. For our latest analysis of Danimer, including current ownership details, please refer to our recent ownership diagnostics report.
Primary Takeaways
Danimer Scientific, a player in the Specialty Chemicals industry, has shown a promising uptick in its stock price today with a price change of 0.02 and a price percent change of 3.7%. However, investors should tread carefully as the company's EPS estimate for the current year stands at a loss of 0.89 and the total risk alpha is at -0.88, indicating a higher risk associated with the stock. Despite the recent gains, the company's risk-adjusted performance of -0.09 and a Treynor Ratio of -0.32 suggest potential volatility in the future. Therefore, while a bullish trend may be on the horizon, investors should consider the inherent risks before investing.Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
Danimer Scientific, a prominent player in the Specialty Chemicals industry, has been making notable gains in the market today, sparking discussions about a potential bullish trend. The company, which is listed on the NYSE, has a Beta of 1.568, indicating a higher volatility compared to the overall market.
Despite the company's estimated loss of $0.89 per share for the current year and a projected loss of $0.55 per share for the next year, the overall analyst consensus leans towards a 'Buy'. This is further reinforced by the Wall Street target price of $1.41, which is significantly higher than the current valuation market value of $0.56.
The stock's 50-day moving average stands at $0.7132, which is lower than the 200-day moving average of $1.0828, suggesting a potential upward trend. Additionally, the company's accumulation distribution figure is at 49.5K, indicating a positive sentiment among investors.
With a possible upside price of $5.9, the potential for significant returns is clear. However, investors should also consider the possible downside price of $0.0056 and the short percent of 0.2129, which indicates a sizable portion of investors betting against the stock. As of July 8, 2024, the balance of power for the day stands at 0.5, suggesting an equilibrium between buyers and sellers.
In conclusion, while Danimer Scientific has been making notable gains today, investors should carefully consider the various factors at play before making a decision. Currently, Danimer Scientific's Tangible Book Value Per Share remains relatively stable compared to the previous year. As of 07/09/2024, the Receivables Turnover is projected to increase to 4.13, while the Price To Sales Ratio is expected to decrease to 2.12. This brief article will discuss Danimer Scientific as a potential investment. We will explore why retail investors should maintain confidence in Danimer Scientific's outlook.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Danimer Scientific. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for Danimer Scientific
How important is Danimer Scientific's Liquidity
Danimer Scientific financial leverage refers to using borrowed capital as a funding source to finance Danimer Scientific ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Danimer Scientific financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Danimer Scientific's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Danimer Scientific's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Danimer Scientific's total debt and its cash.
Danimer Scientific Gross Profit
Danimer Scientific Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Danimer Scientific previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Danimer Scientific Gross Profit growth over the last 10 years. Please check Danimer Scientific's gross profit and other fundamental indicators for more details.
Breaking it down
Danimer Scientific exhibits very low volatility with skewness of -0.65 and kurtosis of 1.46. Danimer Scientific is a potential penny stock. Although Danimer Scientific may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Danimer Scientific. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Danimer instrument if you perfectly time your entry and exit.However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
As the saying goes, "the trend is your friend," and it seems that Danimer Scientific may be on the cusp of a bullish trend. The company, which operates in the specialty chemicals sector, saw notable gains in its stock today, suggesting a potential upward trajectory. Despite a negative return on assets of -0.1 and a high probability of bankruptcy at 96%, the company's shares outstanding stand at 116.44M with a market capitalization of $62.88M. However, with a high short ratio of 34.46X and 22.5M shares short, investors should tread carefully. The company's current valuation is $415.77M, and with a target price of $1.41, there could be potential upside for those willing to take on the risk..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Danimer Scientific. Please refer to our Terms of Use for any information regarding our disclosure principles.